Identifying the mechanisms of action of a novel 8-hydroxy quinazolinone in models of Parkinson's disease [ 2013 - 2015 ]

Research Grant

Researchers: A/Pr Robert Cherny (Principal investigator) ,  A/Pr David Finkelstein

Brief description By the time symptoms of Parkinson's disease (PD) appear, 60-70% of the cells in a crucial part of the brain called the substantia nigra have been destroyed and within a few years of diagnosis, most of the remaining cells have died. This project investigates the causes of this cell loss and a how a new class of compounds could interrupts the process. Success in achieving the aims of this proposal will add to our knowledge of the causes of neuronal death in PD

Funding Amount $AUD 690,927.73

Funding Scheme Project Grants

Notes Standard Project Grant